Home › NDC Lookup › Ingredients › Sennosides › 39328-0020-08
Senna Sennosides 8.8 mg/5mL Syrup, 237 mL — NDC 39328-0020-08 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Senna Sennosides 8.8 mg/5mL Syrup, 237 mL — NDC 39328-020-08 (Billing 39328-0020-08)

by Patrin Pharma, Inc. · 237 mL in 1 BOTTLE, PLASTIC

This is a package of 237 mL of Senna Sennosides 8.8 mg/5mL Syrup from Patrin Pharma, Inc., marketed since Oct 2023 and currently FDA-listed; retail pharmacies pay about $0.0369 per mL (NADAC). It is this product's only package size.

NDC 39328-0020-08
🏷️ FDA NDC (as labeled) 39328-020-08 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 39328-020-08 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
39328 labeler · 020 product · 08 package
Package marketed since
Oct 1, 2023
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
237 mL per package
Barcode (UPC)
0339328120054, 0339328220150
Medicaid fills, this package
35,479 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 39328-020-08
Product NDC 39328-020
11-digit billing NDC 39328002008
NCPDP billing unit ML — per mL (volume)
RxCUI 702311
UNII 3FYP5M0IJX
UPC 0339328120054, 0339328220150
Application # M007
SPL Set ID a9f1ef8d-8700-481f-a709-972bb9d27153
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2023-10-01
Route ORAL
Dosage form SYRUP
Substance SENNOSIDES

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 46200060201220
GPI class Senna
GCN Seq No 002922
GCN 08660
HICL code 001289
Ingredient (HICL) Sennosides
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D6
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Colon
HIC3 code D6S
Therapeutic class — specific (HIC3) Laxatives And Cathartics
AHFS code 56:12.00.00
AHFS class Cathartics And Laxatives
FDB label name SENNA 8.8 MG/5 ML SYRUP
FDB brand name Senna
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 002922
  • GCN: 08660
  • GPI-14 (Medi-Span): 46200060201220
  • HICL (First Databank): 001289
  • AHFS class code: 56:12.00.00
  • RxCUI (RxNorm): 702311
Why two NDCs? The FDA registers this code as 39328-020-08 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 39328-0020-08. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Contact laxatives class.

Drug family (ATC) Contact laxatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name SENNA 8.8 MG/5 ML SYRUP Ingredient Sennosides
📗 Our plain-language guide HelloPharmacist
  • Senna typically produces a bowel movement within 6 to 12 hours. That's why most people take it at bedtime — so it can do its job overnight and you get results in the morning. If no...
  • How long does it take for senna to work?
  • Senna is designed for short-term, occasional use. You should not use it for more than 1 week unless your doctor specifically tells you it's okay. Using laxatives too often or for t...
  • Laxatives like senna can affect how your body absorbs other medications. To be safe, take senna at least 2 hours before or after any other drugs you use. It's always a good idea to...
📖 Read our full Senna guide →
3
Nutrient depletion considerations

Sennosides (OTC drug) may be associated with lower levels of 3 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Sennosides (OTC drug) nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.037 $8.75 / 237 ml
Medicaid paysCMS SDUD · 12 mo $0.0575 $13.63 / 237 ml
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Dec 2025 Mar 2026 Jun 2026 Sep 2026 $0.042 $0.037
▼ Down 12% over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
39328-0020-08 You're viewing this Main listing 237 mL in 1 BOTTLE, PLASTIC 2023-10-01 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Senna Liquid 8.8 mg/5mL 00536-1266-59 RUGBY 237 ml $0.037 — Availability likely —
Senna 8.8 mg/5mLthis 39328-0020-08 Patrin 237 ml $0.037 — Availability likely —
Senna Syrup 8.8 mg/5mL 54859-0808-08 Llorens 237 ml $0.037 — Availability likely —
Senna Syrup 8.8 mg/5mL 57237-0301-24 Rising 237 ml $0.037 — Availability likely —
Senna Syrup 8.8 mg/5mL 58657-0518-08 Method 237 ml $0.037 — Availability likely —
Senna 8.8 mg/5mL 82568-0024-08 AARNA 237 ml $0.037 — Availability likely —
Senna 8.8 mg/5mL 00121-4967-40 PAI 10 cups — — FDA listed —
Senna 8.8 mg/5mL 00536-1483-59 Rugby 237 ml — — FDA listed —
Senna 8.8 mg/5mL 00904-7528-94 Major 10 cups — — FDA listed —
OneLAX SENNA 417.12 mg/237mL 17856-1127-01 ATLANTIC 120 syringes — — FDA listed —
OneLAX SENNA 417.12 mg/237mL 17856-8127-02 Atlantic 50 cups — — FDA listed —
Senna UD 8.8 mg/5mL 39328-0120-50 Patrin 10 cups — — FDA listed —
Senna UD 26.4 mg/15mL 39328-0220-50 Patrin 10 cups — — FDA listed —
Senna Syrup 8.8 mg/5mL 48433-0219-40 Safecor 40 cups — — FDA listed —
Senna Syrup 8.8 mg/5mL 50268-0731-24 AVPAK 24 cups — — FDA listed —
Senna Syrup 8.8 mg/5mL 57237-0310-54 Rising 40 cups — — FDA listed —
GeriCare Senna Syrup 8.8 mg/5mL 57896-0472-08 Geri-Care 237 ml — — FDA listed —
Senna 8.8 mg/5mL 60687-0851-77 American 10 cups — — FDA listed —
Senna Syrup 8.8 mg/5mL 63629-9268-01 Bryant 237 ml — — FDA listed —
SENNA Syrup 8.8 mg/5mL 66424-0562-08 SDA 236 ml — — FDA listed —
Senna 417.12 mg/237mL 68094-0049-62 Precision 10 cups — — FDA listed —
Senna 8.8 mg/5mL 69618-0069-58 Reliable 237 ml — — FDA listed —
OneLAX SENNA 417.12 mg/237mL 71399-0027-08 Akron 237 ml — — FDA listed —
Senna Syrup 8.8 mg/5mL 72090-0022-01 Pioneer 237 ml — — FDA listed —
Senna Syrup 8.8 mg/5mL 72162-1672-02 Bryant 237 ml — — FDA listed —
Senna Syrup 8.8 mg/5mL 73564-0812-08 Aldama 1 bottle — — FDA listed —
Senna Syrup 8.8 mg/5mL 81033-0120-50 Kesin 50 cups — — FDA listed —
Senna Syrup 8.8 mg/5mL 84415-0021-01 Everpharm 100 cups — — FDA listed —
Senna Liquid 8.8 mg/5mL 84447-0120-01 Belleview 200000 ml — — FDA listed —
Curewell Senna Syrup 8.8 mg/5mL 85111-0452-08 RMT 1 bottle — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2023
On the market since
Oct 2023
📍
2026
Currently FDA-listed
3 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color Brown
FlavorChocolate
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII A2I8C7HI9T
    Methylparaben is a preservative derived from benzoic acid that prevents growth of bacteria, fungi, and mold in medicines. It extends the product's shelf life and maintains safety during storage.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII Z8IX2SC1OH
    Propylparaben is a chemical preservative used to prevent bacterial and fungal growth in medicines and personal care products. It helps extend shelf life and maintain product safety during storage.
  • UNII C151H8M554
    A natural sugar derived from sugar cane or sugar beets. It's used as a sweetener, filler, and binder to improve taste, add bulk, and help hold tablet or capsule ingredients together.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

5 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesChocolate flavor, methylparaben, propylene glycol, propylparaben, purified water and sucrose

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerPatrin Pharma, Inc.
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code39328
First marketedOct 2023
Product typeHuman Otc Drug
Portfolio18 products on file

More NDCs from Patrin Pharma, Inc. labeler code 39328

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 How Supplied / Storage and Handling 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 14 words ▾

Uses Relieves occasional constipation (irregularity) Generally causes bowel movement in 6 to 12 hours

⏱️ Dosage and Administration 101 words ▾

Directions Shake well before using. Do not exceed maximum dose. Take at bedtime or as directed by a doctor.

AGE USUAL DOSE MAXIMUM DOSAGE Adults and children 12 years and older 2-3 teaspoons (10 to 15 mL) once a day 3 teaspoons (15 mL) twice a day 6 to 12 years 1 to 1 1/2 teaspoons (5 to 7.5 mL) once a day 1 1/2 teaspoons (7.5 mL) twice a day 2 to 6 years 1/2 to 3/4 teaspoons (2.5 to 3.75 mL) once a day 3/4 teaspoon (3.75 mL) once a day under 2 years of age Consult a doctor

⚠️ Warnings 86 words ▾

Warnings Do not use laxative products for longer than one week unless directed by a doctor. Ask a doctor before use if you have stomach pain, nausea or vomiting notice a change in bowel habits that last over two weeks are pregnant or breast feeding Stop use and ask a doctor if you have rectal bleeding or failure to have a bowel movement after use. Keep out of reach of children.

In case of accidental overdose, get medical help or contact a Poison Control Center immediately.

📦 How Supplied / Storage and Handling 49 words ▾

How Supplied A chocolate flavored syrup supplied in the following oral dosage cup: NDC 39328-120-05: NDC 39328-120-50: 5 mL unit dose cup Case contains 50 unit dose cups of 5 mL NDC 39328-220-15: NDC 39328-220-50: 15 mL unit dose cup Case contains 50 unit dose cups of 15 mL

📦 Storage and Handling 26 words ▾

Other Information Store at controlled room temperature 20-25°C (68-77°F). Excursions permitted 15-30°C (59-86°F). Tamper-Evident: Do not use if foil seal over cup is torn or broken.

🧪 Active Ingredient 12 words ▾

Active ingredient (in each 5 mL = 1 teaspoonful) Sennosides 8.8 mg

🧪 Inactive Ingredients 12 words ▾

Inactive Ingredients Chocolate flavor, methylparaben, propylene glycol, propylparaben, purified water and sucrose

🎯 Purpose 2 words ▾

Purpose Laxative

📄 Do Not Use 15 words ▾

Do not use laxative products for longer than one week unless directed by a doctor.

📄 Ask a Doctor Before Use If 29 words ▾

Ask a doctor before use if you have stomach pain, nausea or vomiting notice a change in bowel habits that last over two weeks are pregnant or breast feeding

📄 Stop Use and Ask a Doctor If 20 words ▾

Stop use and ask a doctor if you have rectal bleeding or failure to have a bowel movement after use.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children. In case of accidental overdose, get medical help or contact a Poison Control Center immediately.

📄 Questions or Comments 18 words ▾

Questions Or Comments? Call (800) 936 3088. You may also report serious side effects to this phone number.

📄 Package Label / Principal Display Panel 127 words ▾

PRINCIPAL DISPLAY PANEL - 237 mL Bottle Label NDC 39328-020-08 Senna Syrup Natural Vegetable Laxative 8.8mg/5 mL Alcohol Free • Dye Free 8 fl. oz (237 mL) PATRIN PHARMA PRINCIPAL DISPLAY PANEL - 237 mL Bottle Label

PRINCIPAL DISPLAY PANEL - 5 mL Cup Label Delivers 5 mL NDC 39328-120-05 Senna Syrup 8.8 mg/5 mL Shake Well For Institutional Use Only See Insert Lot# xxxxxx Exp: yyyy/mm/dd Patrin Pharma Skokie, IL 60076 Rev 03.0124 PRINCIPAL DISPLAY PANEL - 5 mL Cup Label

PRINCIPAL DISPLAY PANEL - 15 mL Cup Label Delivers 15 mL NDC 39328-220-15 Senna Syrup 26.4 mg/15 mL Shake Well For Institutional Use Only See Insert Lot# xxxxxx Exp: mm/dd/yyyy Patrin Pharma Skokie, IL 60076 Rev 02.0823 PRINCIPAL DISPLAY PANEL - 15 mL Cup Label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
35.5K
Units reimbursed last 4 qtrs
7.8M
Gross reimbursed last 4 qtrs
$447.9K
Avg / prescription
$12.62
Avg / unit
$0.0575
Latest quarter Q1 2026
8.3KRx
Medicaid pays / mL
$0.0575
gross reimbursed
vs
NADAC / mL
$0.0369
acquisition cost
=
Spread
+$0.0206
+56% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
43% FFS 57% MCO
Fee-for-service · 15,267 Rx Managed care · 20,212 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: 18,584 units · 946 per 100k residents ID Montana: 28,636 units · 2,530 per 100k residents MT North Dakota: no data reported ND Minnesota: 386,280 units · 6,733 per 100k residents MN Wisconsin: 195,527 units · 3,308 per 100k residents WI Michigan: 331,729 units · 3,305 per 100k residents MI New York: 789,747 units · 4,035 per 100k residents NY Vermont: 24,827 units · 3,837 per 100k residents VT New Hampshire: 46,697 units · 3,331 per 100k residents NH Oregon: 204,235 units · 4,825 per 100k residents OR Nevada: 22,081 units · 691 per 100k residents NV Wyoming: 10,488 units · 1,796 per 100k residents WY South Dakota: no data reported SD Iowa: 103,851 units · 3,238 per 100k residents IA Illinois: 70,171 units · 559 per 100k residents IL Indiana: 238,717 units · 3,479 per 100k residents IN Ohio: 978,316 units · 8,301 per 100k residents OH Pennsylvania: 1,163,275 units · 8,975 per 100k residents PA New Jersey: 197,783 units · 2,129 per 100k residents NJ Massachusetts: 295,727 units · 4,224 per 100k residents MA California: 348,421 units · 894 per 100k residents CA Utah: 31,534 units · 923 per 100k residents UT Colorado: 4,920 units · 83.7 per 100k residents CO Nebraska: 75,991 units · 3,842 per 100k residents NE Missouri: 481,049 units · 7,764 per 100k residents MO Kentucky: 278,545 units · 6,154 per 100k residents KY West Virginia: no data reported WV Virginia: 352,529 units · 4,045 per 100k residents VA Maryland: 106,591 units · 1,725 per 100k residents MD Connecticut: 173,586 units · 4,799 per 100k residents CT Rhode Island: 39,259 units · 3,585 per 100k residents RI Arizona: 152,948 units · 2,058 per 100k residents AZ New Mexico: no data reported NM Kansas: 107,098 units · 3,643 per 100k residents KS Arkansas: no data reported AR Tennessee: 238,005 units · 3,340 per 100k residents TN North Carolina: no data reported NC South Carolina: 259,251 units · 4,825 per 100k residents SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: 21,631 units · 196 per 100k residents GA D.C.: 11,428 units · 1,683 per 100k residents DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
83.78,975
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Pennsylvania 8,975 /100k
2 Ohio 8,301 /100k
3 Missouri 7,764 /100k
4 Minnesota 6,733 /100k
5 Kentucky 6,154 /100k
6 South Carolina 4,825 /100k
7 Oregon 4,825 /100k
8 Connecticut 4,799 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
← 39328-0019-01 · Patrin 39328-0024-15 · Patrin →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.